AIDS onset at high CD4+ cell levels is associated with high HIV load

AIDS Research and Human Retroviruses

Volumn 16, Issue 2, 2000, Pages 103-107

  Hennessey, Karen A ^a,f   Giorgi, Janis V ^b   Kaplan, Andrew H ^b   Visscher, Barbara R ^a   Gange, Stephen ^c   Margolick, Joseph B ^c   Riddler, Sharon ^d   Phair, John ^e   Detels, Roger ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; GENITAL HERPES; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HERPES GENITALIS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPTERIN; RNA, VIRAL; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 0033978650     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309449     Document Type: Article

References (22)

1. 1. Wei X, Ghosh SK, Taylor ME, et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995; 373:117-122.
2. 2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
3. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126(12):946-954.
4. 4. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 1989;2: 114-124.
5. 5. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, and Rinaldo CR Jr: The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-318.
6. 6. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, and Brookmeyer R: Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987;126:568-577.
7. 7. Detels R, Phair JP, Saah AJ, et al.: Recent scientific contributions to understanding HIV/AIDS from the Multicenter AIDS Cohort Study. J Epidemiol [Japan] 1992;2(2):S11-S19.
8. 8. Giorgi JV, Cheng H-L, Margolick JB, et al.: Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experience. Clin Immunol Immunopathol 1990;55:173-186.
9. 9. Fahey JL, Taylor JMG, Detels R, et al.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-172.
10. 10. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, and Kwok S: Rapid and simple PCR assay for the quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994; 32:292.
11. 11. Hoover DR, Black C, Jacopson LP, et al.: Epidemiologie analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-278.
12. 12. Maser H, Ognibene P, Yarchoan R, et al.: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:223-231.
13. 13. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A, and the Multicenter AIDS Cohort Study Group: The risk of pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990;322:161-165.
14. 14. O'Brien WA, Hartigan PM, Martin D, et al.: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:425-431.
15. 15. Boshoff C and Moore PS: Kaposi's sarcoma-associated herpesvirus: A newly recognized pathogen. AIDS Clin Rev 1997-1998:323-347.
16. + T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:332-340.
17. 17. Gorgi JV, Hulein LE, McKeating JA, et al.: Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999;179(4):859-870.
18. 18. Detels R, Leach CT, Hennessey K, et al.: Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis 1994;169:766-768.
19. 19. Golden MP, Sunyoung K, Hammer SM, et al.: Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992;166:494.
20. 20. Clouse KA, Robbins PB, Fernie B, Ostrove JM, and Fauci AS: Viral antigen stimulation of the production of human monokines capable of regulating HIV-1 expression. J Immunol 1989;143:470.
21. 21. Gulick RM, Mellows JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337(11):734-739.
22. 22. Detels R, Munoz A, McFarlane G, et al.: Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280(17):1497-1503.